Royal Bank of Canada
NUTX

Royal Bank of Canada’s Nutex Health NUTX Stock Holding History

Royal Bank of Canada’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32K Sell
338
-20
-6% -$2.45K ﹤0.01% 5693
2025
Q4 		$59K Buy
358
+316
+752% +$41.9K ﹤0.01% 5476
2025
Q3 		$4K Sell
42
-1,156
-96% -$113K ﹤0.01% 6760
2025
Q2 		$149K Buy
+1,198
New +$155K ﹤0.01% 5370
2025
Q1 		– Sell
-859
Closed -$27K – 7108
2024
Q4 		$27K Buy
+859
New +$24.5K ﹤0.01% 5985
2024
Q3 		– Sell
-16
Closed – – 7239
2024
Q2 		$0 Buy
16
+10
+167% +$72 ﹤0.01% 7382
2024
Q1 		$0 Sell
6
-1
-14% -$20 ﹤0.01% 7408
2023
Q4 		$0 Sell
7
-4
-36% -$125 ﹤0.01% 7433
2023
Q3 		$0 Hold
11
– – ﹤0.01% 7410
2023
Q2 		$1K Sell
11
-101
-90% -$8.66K ﹤0.01% 7047
2023
Q1 		$17K Sell
112
-174
-61% -$35.2K ﹤0.01% 6089
2022
Q4 		$81K Buy
286
+282
+7,050% +$54.2K ﹤0.01% 5611
2022
Q3 		$1K Buy
4
+3
+300% +$1.27K ﹤0.01% 7229
2022
Q2 		$1K Buy
+1
New +$1.18K ﹤0.01% 7165

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Royal Bank of Canada's NUTX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Nutex Health (NUTX) stake by 5.6% in Q1 2026, selling an estimated $2.45K and leaving 338 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #5693.

Royal Bank of Canada first reported a position in NUTX in Q2 2022 and has held it in 14 quarters since. The position peaked at $149K in Q2 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Royal Bank of Canada held 338 shares of Nutex Health worth $32K as of Q1 2026.
  • Royal Bank of Canada sold 20 Nutex Health shares in Q1 2026, an estimated $2.45K.
  • Nutex Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5693 holding.
  • Royal Bank of Canada first reported a position in Nutex Health in Q2 2022 and has held it in 14 quarters since.
  • Royal Bank of Canada's Nutex Health position peaked at $149K in Q2 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.